Article info
PDFResearch ethics
Paper
Turning residual human biological materials into research collections: playing with consent
- Correspondence to Dr Eugenijus Gefenas, Department of Medical History and Ethics, Vilnius University, M K Ciurlionio St. 21/27, Vilnius LT-03101, Lithuania; eugenijus.gefenas{at}mf.vu.lt
Citation
Turning residual human biological materials into research collections: playing with consent
Publication history
- Received July 11, 2011
- Revised November 27, 2011
- Accepted February 8, 2012
- First published March 9, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- New European guidelines for the use of stored human biological materials in biomedical research
- Ethics of dead participants: policy recommendations for biobank research
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- Broadening consent—and diluting ethics?
- Stored human tissue: an ethical perspective on the fate of anonymous, archival material
- Webinar report: stakeholder perspectives on informed consent for the use of genomic data by commercial entities
- Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents
- Is the commercialisation of human tissue and body material forbidden in the countries of the European Union?
- The human body as property? Possession, control and commodification
- Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies